CleanUP IPF – Researcher Bios

bios-blankCo-Investigator, Associate Director of Biostatistics
Duke Clinical Research Institute

 

 

Kevin Anstrom, PhD is an Associate Professor in the Department of Biostatistics and Bioinformatics at Duke University, and the Associate Director of Biostatistics at the Duke Clinical Research Institute (DCRI).

KEVIN ANSTROM, PhD is an Associate Professor in the Department of Biostatistics and Bioinformatics at Duke University, and the Associate Director of Biostatistics at the Duke Clinical Research Institute (DCRI).

Dr. Anstrom earned his bachelor’s degree in Statistics and Biometry at Cornell University, his master’s in Biostatistics at University of North Carolina at Chapel Hill, and his doctorate in Statistics from North Carolina State University. As part of his dissertation research, Dr. Anstrom developed inverse propensity score weighted estimators for average causal effects in randomized and nonrandomized studies. Dr. Anstrom is the author of more than 220 publications with a focus on clinical trials, propensity score methods, registry-based studies, and economic and quality-of-life studies.

From 2005-2014, Dr. Anstrom was the Principal Investigator for the Data Coordinating Center of the Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet), an NHLBI funded network of 26 U.S. clinical sites designed to conduct numerous clinical trials each with associated ancillary and substudies. The results of the IPFnet clinical trials have influenced the standard of care for patients with IPF. Dr. Anstrom serves as the Principal Investigator several clinical trials and research networks including: Heart Failure Network, TACT-2, TRANSFORM-HF, SPIRRIT-HFpEF, Wrap-IPF, GUIDE-IT, PAL-HF, CALYPSO, and SAFE-PCI. He has served as statistician for numerous Data and Safety Monitoring Committees on industry-funded and federally-funded projects.

 

bios-blankChief, Pulmonary and Critical Care Medicine
Weill Cornell Medical College

 

 

Professor Martinez’s main research interests include the biological underpinnings and therapeutic approaches to interstitial lung diseases and chronic obstructive pulmonary disease (COPD).

Fernando J. Martinez, MD, MS, is Chief of the Division of Pulmonary and Critical Care Medicine
at Weill Cornell Medical College in New York City. Prior to this appointment, he was professor of internal medicine and associate chief for clinical research in the Division of Pulmonary and Critical Care Medicine at the University of Michigan Health System, Ann Arbor, Michigan, as well as medical director of its Pulmonary Diagnostic Services and co-medical director of the Lung Transplantation Program. After graduating from the University of Florida School of Medicine in Gainesville, Florida, he completed a residency in internal medicine at Beth Israel Hospital, Boston, Massachusetts, and a fellowship in pulmonary medicine at the Boston University Pulmonary Center. He received a Masters in Biostatistics and Clinical Study Design from the University of Michigan School of Public Health.

Professor Martinez’s main research interests include the biological underpinnings and therapeutic approaches to interstitial lung diseases and chronic obstructive pulmonary disease (COPD). He is a member of numerous societies, including the American Thoracic Society, the European Respiratory Society, and the American College of Chest Physicians. Previously, he was a member of the American Thoracic Society Committees which generated guidelines for the management of COPD, respiratory infections, idiopathic pulmonary fibrosis, and cardiopulmonary exercise testing. He is the former chair of the Clinical Problems Assembly of the American Thoracic Society. Professor Martinez is a member of the GOLD Science Committee and sits on a number of editorial boards, including for Journal of COPD and American Journal of Respiratory and Critical Care Medicine. He serves as a deputy editor for the latter.

 

bios-blankChief of the Division of Pulmonary and Critical Care Medicine
University of Virginia

 

 

Dr. Noth is a premiere translational researcher in Interstitial Lung Disease. Over the last decade and a half, he has concentrated his efforts on interstitial lung diseases with a special emphasis on idiopathic pulmonary fibrosis (IPF).

Dr. Imre Noth received his Bachelor of Arts from the University of Pennsylvania. He then went on to a Masters of Science in Human Physiology at Georgetown University and received his M.D. the University of Arizona College of Medicine. He completed a residency in Internal Medicine at the University of California at Davis Medical Center in Sacramento, CA. He then pursued a Pulmonary and Critical Care Fellowship at the University of Chicago, where upon completion in 1999 he joined the faculty. He rose to the rank of Professor of Medicine at the University of Chicago in 2012. Dr. Noth recently joined the University of Virginia as the Chief of the Division of Pulmonary and Critical Care Medicine in 2018.

Dr. Noth is a premiere translational researcher in Interstitial Lung Disease. Over the last decade and a half, he has concentrated his efforts on interstitial lung diseases with a special emphasis on idiopathic pulmonary fibrosis (IPF). This translational work has focused on genetics, and genomics of IPF. His lab completed the first of its kind pharmacogenomics study in the field. Dr. Noth has participated–and continues to participate–as principal investigator in numerous clinical trials funded by industry and the NHLBI/NIH that focus predominantly on IPF. As the principal investigator for a U10 award, he was a member of the National Institutes of Health sponsored IPF clinical research network and served on the executive committee for the IPFnet. He NIH funding is currently focused on structure and function of TOLLIP in IPF, which his lab identified as associated with IPF susceptibility and survival. He has also collaborated on other RO1 and UO1 awards.